NCT03977051

Brief Summary

To describe the beliefs, understanding and experience of immunosuppressant medication adherence in our current transplant patient population through a series of patient focus groups

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 8, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 25, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 20, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2017

Completed
2 years until next milestone

First Posted

Study publicly available on registry

June 6, 2019

Completed
4.9 years until next milestone

Results Posted

Study results publicly available

April 12, 2024

Completed
Last Updated

April 12, 2024

Status Verified

October 1, 2023

Enrollment Period

4 months

First QC Date

April 25, 2017

Results QC Date

October 18, 2019

Last Update Submit

October 25, 2023

Conditions

Keywords

Kidney transplantation

Outcome Measures

Primary Outcomes (3)

  • Number of Kidney Transplant Patients Who Expressed an Understanding of the Term Immunosuppression Medication Adherence and the Importance Immunosuppression Medication Adherence Post Transplant

    Through a series of focus groups, the investigators will qualitatively explore kidney transplant patients' understanding of the terms immunosuppressant medication adherence and nonadherence. What importance do patients attach to adherence. Do patients understand that nonadherence may effect the outcome of the transplant. The focus groups will identify the common practical and perceptual barriers to adherence identified by transplant patients and the interventions kidney transplant patients have used to try and improve their adherence. The focus groups will identify which interventions patients have found effective and which interventions patients have not found to be effective to improve their adherence. They will also identify support patients have had with adherence since their transplant, the support patients feel could have helped them to better adhere to their medicines up to now and the support our patients feel would help them to adhere better to their medicines in the future

    4 months

  • Number of Kidney Transplant Patients Who Identified Interventions to Support Immunosuppressant Medication Adherence

    Through a series of focus groups, the investigators will qualitatively explore kidney transplant patients' understanding of the terms immunosuppressant medication adherence and nonadherence. What importance do patients attach to adherence. Do patients understand that nonadherence may effect the outcome of the transplant. The focus groups will identify the common practical and perceptual barriers to adherence identified by transplant patients and the interventions kidney transplant patients have used to try and improve their adherence. The focus groups will identify which interventions patients have found effective and which interventions patients have not found to be effective to improve their adherence. They will also identify support patients have had with adherence since their transplant, the support patients feel could have helped them to better adhere to their medicines up to now and the support our patients feel would help them to adhere better to their medicines in the future

    4 months

  • Number of Patients Who Identify Barriers to Immunosuppression Medication Adherence

    Through a series of focus groups, the investigators will qualitatively explore kidney transplant patients' understanding of the terms immunosuppressant medication adherence and nonadherence. What importance do patients attach to adherence. Do patients understand that nonadherence may effect the outcome of the transplant. The focus groups will identify the common practical and perceptual barriers to adherence identified by transplant patients and the interventions kidney transplant patients have used to try and improve their adherence. The focus groups will identify which interventions patients have found effective and which interventions patients have not found to be effective to improve their adherence. They will also identify support patients have had with adherence since their transplant, the support patients feel could have helped them to better adhere to their medicines up to now and the support our patients feel would help them to adhere better to their medicines in the future

    4 months

Study Arms (1)

Focus group

Focus group to explore immunosuppressant medication adherence in kidney transplant patients

Behavioral: Focus group

Interventions

Focus groupBEHAVIORAL

Kidneys transplant patients will discuss their attitudes and beliefs towards immunosuppressant medication adherence

Focus group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Kidney transplant patients

You may qualify if:

  • Kidney transplant recipients transplanted and under the active follow up of ICRTC.
  • Speak and understand English
  • years and above

You may not qualify if:

  • Unable to speak and understand English
  • Below 18 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Imperial College Renal and Transplant Centre

London, W12 0HS, United Kingdom

Location

MeSH Terms

Conditions

Medication Adherence

Interventions

Focus Groups

Condition Hierarchy (Ancestors)

Patient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Results Point of Contact

Title
Dawn Goodall
Organization
Imperial College London

Study Officials

  • Dawn Goodall, MSC, BSc

    Imperial College Healthcare NHS Trust

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 25, 2017

First Posted

June 6, 2019

Study Start

February 8, 2017

Primary Completion

June 20, 2017

Study Completion

June 20, 2017

Last Updated

April 12, 2024

Results First Posted

April 12, 2024

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

IPD will not be shared

Locations